ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2022

Effects of Ultra-Long-Acting Insulin Compared to Long-Acting Insulin on Diabetic Ketoacidosis Incidence in Type 1 Diabetes Mellitus Patients.

Wafa A Alsofiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.